Lymfadenitis door niet-tuberculeuze mycobacteriën, chirurgische of antibiotische behandeling?

Tijdschrift voor Kindergeneeskunde

Volumn 67, Issue 3, 1999, Pages 140-143

  Miedema, C J ^a,e   Geelen, S P M ^b   De Langen, Z J ^c   Pekelharing Berghuis, M ^d   Kimpen, J L L ^b  

^a CATHARINA HOSPITAL   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d DEPARTMENT OF SURGERY   (Netherlands)

^e Diaconessenhuis   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CLARITHROMYCIN;

ANTIBIOTIC THERAPY; ARTICLE; CASE REPORT; CHILD; CONSERVATIVE TREATMENT; DRUG EFFECT; EXCISION; HUMAN; LYMPHADENITIS; MYCOBACTERIUM INTRACELLULARE AVIUM; MYCOBACTERIUM TUBERCULOSIS; PUNCTURE; RECURRENT DISEASE;

EID: 0007948513     PISSN: 03767442     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Wolinsky E. Mycobacterial lymphadenitis in children: a prospective study of 105 nontuberculous cases with longterm follow-up. Clin Inf Dis 1995,20.954-63.
2. Kuypers FY, Zwierstra RP, Langen ZJ de. De chirurgische behandeling van lymfadenitis door niet-tuberculeuze mycobacterien bij kinderen. Ned Tijdschr Geneeskd 1995;139:2036-9.
3. Schneider MME, Reiss P, Borleffs JCC, Rozenberg-Arska M, Hoepelman IM. Mycobacterium avium-infectie bij HIV-geinfecteerde patiënten: epidemiologie, diagnose, profylaxe en behandeling. Ned Tijdschr Geneeskd 1997;141:80-3.
4. Chaisson RE, et al. Clarithromycin therapy for bacteremic Mycobacterium avium complex disease. A randomized, double-blind, dose-ranging study in patients with AIDS. Ann Intern Med 1994;121:905-11.
5. Leverstein H, Snow GB. De chirurgische behandeling van lymfadenitis door niet-tuberculeuze mycobacterien bij kinderen. Ned Tijdschr Geneeskd 1995;139:2451.
6. Berger C, Pfyffer GE, Nadal D. Treatment of nontuberculous mycobacterial lymphadenitis with clarithromycin plus rifabutin. J Pediatr 1995;18: 383-6.
7. Sigalet D, Lees G, Fanning A. Atypical tuberculosis in the pediatric patient: implications for the pediatric surgeon. J Pediatr Surg 1992;27:1381-4.
8. Laag vd J, Pronk A, Pull ter Gunne AJ, Bax NM. Niet-tuberculeuze mycobacteriele lymfadenitis. Ned Tijdschr Geneeskd 1990;134:904-8.
9. Falkinham JO. Epidemiology of infection by non-tuberculous mycobacteria. Clin Microbiol Rev 1996;9:177-215.
10. Huebner RE, Maybelle FS, Cauthen GM, et al. Usefulness of skin testing with mycobacterial antigens in children with cervical lymphadenopathy. Pediatr Infect Dis J 1992;11:450-6.
11. Miedema CJ, Hermans PWM, Kimpen JLL. Diagnostiek van tuberculose bij kinderen. Tijdschr Kindergeneeskd 1996;64:250-5.
12. Schaad UB, Votteler TP, McCracken GH jr, Nelson JD. Management of atypical mycobacterial lymphadenitis in childhood: a review based on 380 cases. J Pediatr 1979;95:356-60.
13. Grange JM, Portaels F. Disease of children caused by environmental mycobacteria. Tijdschr Kindergeneeskd 1996;64:255-65.
14. Clark JE, Magee JG, Cant AJ. Non-tuberculous mycobacterial lympadenopathy. Arch Dis Child 1995;72:165-6.
15. Tessier MH, Amoric JC, Mechinaud F, dubesset D, Litoux P, Stalder JF. Clarithromycin for atypical mycobacterial lymphadenitis in non-immunocompromised children. Lancet 1994;344:1778.
16. Brown BA, Wallace RJ, Onyi GO. Activities of clarithromycin against eight slowly growing species of nontuberculous mycobacteria, determined by using a broth microdilution MIC system Antimicrob Agents Chemother 1992;36:1987-90.
17. Yajko DM, Sanders CA, Mandej JJ, et al. In vitro activities of rifabutin, azithromycin, ciprofloxacin, clarithromycin, clofazimine, ethambutol, and amikacin in combinations of two, three, and four drugs against mycobacterium avium. Antimicrob agents chemother 1996;40:743-9.
18. Green PA, Fordham von Reyn C, Smith RP. Mycobacterium avium complex parotid lymphadenitis: successful therapy with clarithromycin and ethambutol. Pediatr Infect Dis J 1993;12:615-6.
19. Holland SM, et al. Treatment of refractory disseminated non-tuberculous mycobacterial infection with interferon gamma. N Engl J Med 1994;330:1348-55.
20. Levin M, et al. Familial disseminated atypical mycobacterial infection in childhood: a human mycobacterial susceptibility gene? Lancet 1995;345:79-83.
21. Newport MJ, et al. A mutation in the interferon-γ-receptor gene and susceptibility to mycobacterial infection. N Engl J Med 1996;335:1941-9.